Context Therapeutics Inc.

NASDAQ:CNTX

Biotechnology

Healthcare
$0.69 +2.93%

+$0.02 today

Market cap
$63.67M
Beta
1.61
P/E (TTM)
-1.5
EPS (TTM)
-$0.42
52W Low $0.56High $3.62

Volume 1.71M

Average 1.16M

Returns on capital

Context Therapeutics Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-59.7%

avg -52.4%

ROIC

-65.5%

avg -3.4%

ROA

-52.7%

avg -171.5%

Analysis

ROA is currently the strongest return metric at -52.7% versus its period average of -171.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Martin A. Lehr

Co-Founder, President, Chief Executive Officer & DirectorUSD 914.02K42815.00K0.89%

Jennifer Minai-Azary

Chief Financial Officer & TreasurerUSD 610.73K48——

Alex C. Levit

Chief Legal Officer & Corporate SecretaryUSD 576.31K47270.00K0.29%

Karen Chagin

Chief Medical OfficerUSD 26.61K49——

Jennifer Dashnau

Senior Vice President of Technical Operations————

Christopher Beck

Senior Vice President of Operations————

Jeffrey Liebman

Associate Director of Accounting————

Compensation is shown in the reported currency; data updated Jul 25, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Feb 19, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A5 analysts
RevenueN/AN/AN/A
N/A6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Context Therapeutics Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CNTX's management, answered from reported figures.

Who manages CNTX?

Context Therapeutics Inc. (CNTX) lists 7 active executives. The top listed executive is Jennifer Minai-Azary, Chief Financial Officer & Treasurer.

Are CNTX insiders buying or selling?

Recent insider activity shows net buying of $8.75M.